Advertisement

Topics

Johnson and Johnson (France) Company Profile

19:32 EDT 29th August 2016 | BioPortfolio

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

These companies are organized into three global business units:

Central Nervous System and Internal Medicine

This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.

B.I.O. (Biotechnology, Immunology & Oncology)

This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.

Virology

This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.

Location

rue camille desmoulins
issy les moulineaux cedex 9
F-92787
France

Contact

Phone: 33-155004174


News Articles [1476 Associated News Articles listed on BioPortfolio]

New VP, Investor Relations At Johnson & Johnson

Johnson & Johnson has appointed Joseph Wolk vice president of investor relations, replacing Louise Mehrotra, who will retire in January...   

M&As this week: Johnson & Johnson, DNA2.0

Johnson & Johnson has announced its plans to acquire Neostrata, its affiliates and Tristrata Incorporated.

BRIEF-Johnson & Johnson says collaborating with HP Inc's unit

* Johnson & Johnson announces collaboration with HP Inc. subsidiary to create personalized health care solutions with 3D printing technologies

BRIEF-Johnson & Johnson reports Q1 EPS of $1.54

April 19 (Reuters) - Johnson & Johnson Says Increased Its Adjusted Earnings Guidance For Full

#jobs #lifescience Johnson & Johnson: Discovery Scientist Oncology – Hematologic Malignancies – UK

// Competitive Salary: Johnson & Johnson: ‘Caring for the world, one person at a time’… inspires and unites the people of Johnson & Johnson… UK from Job Search RSS http://ift.tt/...

Johnson & Johnson Tops 2Q Forecasts Despite Profit Drop

NewsSurging second-quarter sales of Johnson & Johnson's prescription drugs were more than offset by a one-time gain a year ago, but the health care giant easily beat Wall Street's expectations.

Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries

Johnson & Johnson was ordered by a Texas federal jury to pay $490 million to five plaintiffs who claimed they were injured by the company's hip implants.

Johnson & Johnson: Neuer Star im Pharma-Geschäft

von Birgit Haas, Euro am Sonntag Alex Gorsky ist ein Gewächs der Pharmabranche. Der Vorstandsvorsitzende des amerikanischen Konsumgüter- und Pharmariesen Johnson & Johnson (J & J) trieb bereits bei....

PubMed Articles [312 Associated PubMed Articles listed on BioPortfolio]

Reformulation of the D3(Becke-Johnson) Dispersion Correction without Resorting to Higher than C6 Dispersion Coefficients.

A reformulated version of Grimme's most recent DFT dispersion correction with Becke-Johnson damping (DFT-D3(BJ)) is presented, which only depends on C6 dispersion coefficients. The role of the higher ...

9 years of a single referral centre management of Stevens - Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) corresponds to a rare and acute life-threatening mucocutaneous reactions characterized by extensive necrosis and epidermal detachmen...

Chronic Conditions: Beckett, Bergson and Samuel Johnson.

This article analyses the work of the twentieth-century late modernist Samuel Beckett, in light of the turn-of-the-century anti-rationalist Henri Bergson (1859-1941) and the eighteenth-century neoclas...

Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.

Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are life-threatening and severe adverse cutaneous drug reactions characterized by epidermal detachment presenting as blisters and ar...

An Intractable Case of Prototheca Keratitis and Chronic Endophthalmitis in Stevens-Johnson Syndrome With Boston Type 1 Keratoprosthesis.

To report a case of recalcitrant Prototheca spp. keratitis and endophthalmitis in a patient with Stevens-Johnson syndrome (SJS) and Boston type 1 keratoprosthesis (B1 KPro).

Clinical Trials [354 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [465 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "Johnson and Johnson (France)" on BioPortfolio

We have published hundreds of Johnson and Johnson (France) news stories on BioPortfolio along with dozens of Johnson and Johnson (France) Clinical Trials and PubMed Articles about Johnson and Johnson (France) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson and Johnson (France) Companies in our database. You can also find out about relevant Johnson and Johnson (France) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record